Bronchoscopes Market Size was valued at USD 2.7 Billion in 2023. The Global Bronchoscopes industry is projected to grow from USD 2.9 Billion in 2024 to USD 4.6 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2024 - 2032). It is a method for diagnosing the abnormalities in the breathing system function. Bronchoscopes have been adopted by various regions and countries where it has become an important part of the medical unit.
Bronchoscopes are the devices that are to be inserted into the patient’s body i. E into the nose, mouth, and within the trachea thus visualizing the inside body of the patient’s body. An advanced bronchoscope is introduced for diagnosing the disease of the trachea and bronchi. The important factors that help in driving the market of bronchoscopes are the rise in prevalence of respiratory tract disorders for detection of lung cancer, COPD, rise in bronchoscopy procedures and rise in the number of medical organizations.
Ambu Inc. announced in July 2022 that the United States Food and Drug Administration (FDA) has given its consent for Ambu aScopeTM 5 Broncho, a range of sterile single-use bronchoscopes.
In May 2022, Olympus was granted a group purchasing agreement with Premier, Inc. under the Single-Use Visualization Devices category for their single-use bronchoscope portfolio.The Olympus single-use bronchoscope portfolio included five premium H-SteriScopessingle-use bronchoscopes that are used as an adjunct to Olympus' leading re-usable bronchoscope portfolio.
In September 2021, Ambu A/S unveiled the European regulatory clearance for their combined product Ambu® aScope™ 4 Broncho Sampler Set, which is a combination of a Single-Use Bronchoscope and Specimen Sampling System intended to carry out Bronchial Wash (BL) and Bronchoalveolar Lavage (BAL) procedures together with improved workflow, safety and high efficiency.
Similarly, Boston Scientific Corporation received U.S. FDA 510(k) clearance in August 2021 for the EXALT Model B Single-Use Bronchoscope designed specifically for bedside procedures in the intensive care unit (ICU) and operating room.
April 2021 saw Richard Wolf GmbH open its subsidiary in Madrid, Spain, known as Richard Wold Endoscopia Ibérica S.L. This was part of their plan to be a global player.
Hoya Corporation also announced about technical collaboration with Hitachi in May 2021 as part of the five-year contract where they would extend their endoscopic units. Moreover, diagnostic ultrasound systems and sensors will be supplied under this partnership.
Also, in May 2021, PENTAX Medical Europe achieved CE mark accreditation for its new single-use bronchoscope -the PENTAX Medical ONE Pulmo. This revolutionized product offers excellent care without sacrificing lung health. The PENTAX Medical ONE Pulmo is a single-use bronchoscope that has better suction and high-definition image quality.
Olympus Corporation acquired Veran Medical Technologies, Inc. in December 2020. This leading advanced medical devices provider specializes in interventional pulmonology, and the acquisition helped Olympus expand its pulmonary portfolio.
In May 2020, Fujifilm Holdings Corporation announced a number of global milestones and developments toward strengthening their endoscopy and endoscopic health business, including the addition of artificial intelligence, high-tech image acquisition and sophisticated data analysis.
It has been marked that before COVID and the improvement lockdown and shutdown, the market of bronchoscopes was attaining a top position and was expanding to a high level. Due to the strict regulations put forward by the government and the lockdowns and shutdowns of industries and manufacturers suffered from various hardships like the absence of any manufacturing parts, supply, man force, and many others.
Due to the outbreak of the pandemic, the rise in the aging population and the patient’s inflow was more in medical device and clinics which gradually increased the demand for bronchoscopes and raised the bronchoscopes market size. Globally and regionally, all the bronchoscopes industries have taken all the required steps for raising their production and also the supply, which increases the demand for various other products, making it cost-effective to return to its past growth.
Drivers- in the year 2015, WHO detected that about 64 million people are suffering from COPD(Chronic Obstructive Pulmonary Disease) and about 3 million have died due to COPD and a further 1.8million of the population are suffering from lung cancer. The rise in respiratory disorders and the improvement of various policies of the government and the growth in the aging population are the main market drivers of the market.
The rise in giving priority to using invasive procedures and the increase in the number of unique procedures are the important factors promoting the expansion of bronchoscopes market size. Along with it some of the other factors like no cross-contamination, least costs while reprocessing, and increase in availability helps in the market expansion of bronchoscopes. Opportunities- reusing the bronchoscope devices improves the bronchoscopes market share. The flexible bronchoscope is used for multi-usage and cost-effectiveness which are very much useful in clinics and hospitals.
This helps in the widespread development of the industry. The single-use bronchoscope is much more effective and is safe for tools to give protection from pathogens, viruses, and bacteria which even cause death in many humans. These are helpful for the detection of diseases like tumors, COPD, cancer of the lungs, and many more. These bronchoscope devices help in the reduction of infection. Challenges- bronchoscopes causing various disorders and infection is a main challenging factor for the bronchoscopes industry which hampers the bronchoscopes market trends. The rise in cost coupled with the bronchoscopes and the product recalls is another challenging factor for covering the market share of bronchoscopes thus hampering the growth of the industry.
Cumulative growth- urbanization, rise in investment made by the government. An increase in several healthcare sectors acts as a growth-promoting factor for the industry. Restraints- high expenses of the bronchoscopes and the prevalence of the high risk of infection, helps in hindering up the bronchoscopes market share. Flexible devices of bronchoscopes are of high cost because they are insignificantly used for improving their efficiency and their versatility.
By type- based on the segmentation type, it has been marked that the market of bronchoscopes is divided into type, use, application, and end-users. Based on the type, the bronchoscopes are classified into flexible and rigid and EBUD bronchoscopes. Based on application, the market of bronchoscopes is segmented into diagnosis and surgical procedures. Based on end-users the industry is differentiated into hospitals, clinics, and medicals. Based on region, the market of bronchoscopes is divided into North America, Europe, Asia-Pacific, and many more. as per the type, the market of bronchoscopes is divided into flexible bronchoscopes and rigid bronchoscopes. A flexible bronchoscope helps in diagnosing the disease in the trachea and bronchi as well. This division is further subdivided into fiber optic bronchoscopes and video bronchoscopes. As per the application, it has been found that the diagnosis market is divided into examination, the bleeding lungs, chronic cough if lung cancer is present, the airways of a patient, and obtaining tissue specimens for biopsy.
The surgical procedure is categorized into the removal of a foreign substance present in the airway and lase resection of tumors and many more. Based on end-users, it has been found that the market is classified into hospitals and clinics, diagnostic centers, and many more. Hospitals and clinics hold the largest market CAGR of 49.1%. It has been found that the diagnosis holds the most dominant share of 885.7 million and its projects are at USD 1484.2 million till the forecast period of 2023.
According to tot he uses, the bronchoscope industry is classified based on usability by the reusable bronchoscopes and disposable bronchoscope, from all these, the reusable bronchoscope covers a large market share in 2019 for having high quality for imaging. Likewise, the disposable bronchoscope grows at the highest rate and covers a large space.By technology- technology led to the discovery of introducing autofluorescence imaging and imaging of narrowband having some of its additional characteristics. The flexible bronchoscope devices are in high demand in various emerging regions and some of the developing countries which give appropriate results and can diagnose diseases in both trachea and bronchi. Technology also led to the discovery of rigid bronchoscope devices and EBUS bronchoscopes which gave appropriate results.
November 2022: With the release of the EB-710P, a new compact video bronchoscope, Fujifilm India has bolstered its selection of pulmonology solutions. The EB-710P is a lightweight endoscope with a CMOS sensor that is very small for its class. Because of this innovation, the tip is just 4.1 mm in diameter, making it possible to reach further into the lung than with a more traditional approach. In addition, the endoscope may be rotated back to its original position before being withdrawn securely. In addition, the rotation function's teardrop-shaped dial and ergonomic grip allow for easy use. The EB-710P endoscope system is designed to make bronchoscopies safer and more tolerable for patients by virtue of its exceptionally tiny diameter and rotating capability.
March 2023: Chinese University of Hong Kong (CUHK) thoracic surgeons pioneered the use of robotic-assisted bronchoscopic microwave ablation (RBMA) to treat lung metastases in a way that spares healthy lung tissue. The primary therapy for lung metastases is surgical resection, which has the risks of traumatic surgical access and the loss of healthy lung tissue. This unique treatment allows physicians to precisely reach peripheral parts of the lung and execute non-invasive lung sparing microwave ablation of lung metastases, building on the thoracic surgical team's track record of innovation in advanced minimally invasive procedures employing cutting-edge technology. The clinical experiment is now recruiting up to 145 participants from all across the world.
Globally and regionally, the presence of high population and spending a huge sum on healthcare and well-developed healthcare sector. In the North American industry, it has been found that more of the investment is made in the healthcare centers whereas it got more support from the government research and its policies. North America is expected to cover a large area of market share during the market forecast period. The United States conducts 500,000 procedures each year. This helps in steering up the bronchoscopes market size. The European market of bronchoscopes holds the second largest market share as it has developed healthcare units. Along with this, the people here are spending too much on respiratory diseases and medicals and clinics. Due to the rise of awareness about the availability of treatment, the increase in several narrow people here, high patient inflow, and the innumerous rise in healthcare expenditure. The Middle East and African regions contribute to certain limited growth.
Olympus discovered two unique and new endoscopes which are used for periphery and as small anatomy bronchoscopy. They are named BF-190 and BF-XP 190. The flexible endoscope was found to be so much developed. Here in this endoscope, it was found that the video clips help in the transmission of video visuals which helps in monitoring through the scope or wirelessly. This reduces the width of the endoscope.
Of all the key players, Olympus was found to be the most dominant bronchoscopes market player as it has used the advanced developments so made and has attained a successful position. These key players used all the latest technology so made and either merged, did partnership or made collaboration with other key players.
| Attribute/Metric | Details |
| Market Size 2032 | USD 4.6 Billion |
| Compound Annual Growth Rate (CAGR) | 8.90% (2024-2032) |
| Base Year | 2021 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2020 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Market Opportunities | Reusing the bronchoscope devices improves the bronchoscopes market share |
| Key Market Dynamics | Chronic Obstructive Pulmonary Disease |
Bronchoscopes Market Highlights:
Frequently Asked Questions (FAQ) :
The Bronchoscopes Market valuation would be USD 4.6 Billion by 2032.
The CAGR of Bronchoscopes Market would be 8.90% for the forecast period (2024-2032).
The segments are rigid bronchoscopes and flexible bronchoscopes.
Diagnosis and surgical procedure are two processes included in the report.
The end users are diagnostic centers, hospitals & clinics, and others.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
